Table 3.
Statistical analysis of the difference between COVID-19 group and controls
| Cases | Mean (%) | SE | P value |
|---|---|---|---|
| E-selectin | |||
| COVID-19 | 1,07 | ±0.28 | |
| ARDS | 1,88 | ±0.22 | .2524 |
| Pneumonia | 2,46 | ±0.34 | .0159a |
| Neoplasia | 1,52 | ±0.34 | .7551 |
| Normal | 0,84 | ±0.41 | .9652 |
| P-selectin | |||
| COVID-19 | 6,55 | ±0.50 | |
| ARDS | 0,28 | ±0.14 | <.0001c |
| Pneumonia | 0,26 | ±0.06 | <.0001c |
| Neoplasia | 0,60 | ±0.24 | <.0001c |
| Normal | 0,58 | ±0.15 | <.0001c |
| PSGL-1 | |||
| COVID-19 | 77,25 | ±5.65 | |
| ARDS | 20,92 | ±4.14 | <.0001c |
| Pneumonia | 45,36 | ±8.11 | .002b |
| Neoplasia | 27,50 | ±5.25 | <.0001c |
| Normal | 18,48 | ±3.72 | <.0001c |
| ICAM-1 | |||
| COVID-19 | 1,18 | ±0.56 | |
| ARDS | 4,04 | ±1.15 | .0555 |
| Pneumonia | 3,44 | ±1.02 | .1687 |
| Neoplasia | 1,82 | ±1.03 | .9524 |
| Normal | 2,54 | ±0.47 | .5958 |
| VCAM-1 | |||
| COVID-19 | 2,17 | ±1.02 | |
| ARDS | 6,40 | ±2.14 | .3627 |
| Pneumonia | 17,10 | ±3.93 | <.0001c |
| Neoplasia | 5,30 | ±1.22 | .6281 |
| Normal | 5,68 | ±1.65 | .5307 |
| CD11b | |||
| Normal | 6,82 | ±0.89 | <.0001c |
| COVID-19 | 46,76 | ±5.38 | |
| ARDS | 27,38 | ±6.70 | .0359a |
| Pneumonia | 17,62 | ±4.51 | .0011b |
| Neoplasia | 12,76 | ±2.05 | .0002c |
ARDS, acute respiratory distress syndrome.
a
P < 0.05.
b
P < 0.005.
c
P < 0.001.